drugset / Trial / NCT00972738

Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)

NCT00972738

Phase 3 Completed 1214 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the treatment effect of montelukast versus placebo over a 2 week period in patients with seasonal allergic rhinitis. Loratadine is included in the study as an active comparator.

Timeline

Start
2001-04
Primary completion
2001-07
Completion
2001-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Loratadine Small molecule 10 mg Oral
Subject Montelukast Other / unclassified 10 mg Oral